Analystreport

Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Robert W. Baird from $23.00 to $18.00.

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana